About Tigermed

Our Company

Culture & Values

Leadership

Global Locations

Corporate Compliance

Subsidiaries & Joint Ventures

Diversity & Inclusion

20th Anniversary

Tigermed International

Tigermed EMEA

Media & Resources

Press Releases

Events

Tigermed Insights

Resource Library

Cloud Classroom

Environment, Social and Governance (ESG)

Sustainability & ESG Report

ESG Management

Corporate Responsibility

Corporate Video

We are committed to supporting our clients in their clinical development in the best possible way.

By Phase

Preclinical

Early Phase

Phase II-III Clinical

Post-Marketing

Real World Study

Preclinical Development

Medicinal Chemistry

Compound Screening

DMPK

Safety & Toxicology

Bioanalytical

CMC

Clinical Development

Medical Writing

Clinical Monitoring

Regulatory Affairs

Data Management and Statistical Analysis

Clinical Development Strategy

Decentralized Clinical Trials (DCTs)

Site Management (SMO)

Medical Device / IVD

Multi-region Clinical Trial (MRCT)

Vaccine Clinical Trial

Integrated Capabilities

Medical Imaging

Pharmacovigilance

Medical Translation

Quality Assurance

GMP Consulting

Central Laboratories

Functional Service Provider (FSP)

Participant Management

EDC System

Remote Follow-up Center

Therapeutic Expertise

Cell and Gene Therapy

GLP-1 RA

Radiopharmaceutical

Infectious Diseases

Oncology

Hematology

Cardiovascular

Endocrinology

Rheumatology

Central Nervous System

Gastroenterology

Ophthalmology

Careers

Talent Development

Enjoy Your Life with Tigermed

Join Tigermed (China)

Join Tigermed (Global)

Global Locations

Discover our offices across Asia, US, Europe, Latin America and Africa.

Career Opportunities

Explore your career opportunities worldwide with Tigermed.

Investors

Corporate Governance

Financial Reports and Presentations

Announcements

Prospectus

Investor Contact

Tigermed 2025 Annual Results Presentation

View Tigermed 2025 Annual Results Presentation

ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2025

Contact

Business Enquiry / RFP

Client Service Center

Media & Investors Enquiry

Compliance Concern

Business Enquiry / RFP

Email: marketing@tigermedgrp.com

Client Service Center

Email：clientservice@tigermedgrp.com

Media & Investors Enquiry

Email：PR@tigermedgrp.com

Compliance Concern

Email: compliance.officer@tigermedgrp.com

QUICK LINKS

  • Preclinical
  • Early Phase
  • Phase II-III Clinical
  • Post-Marketing
  • Real World Study
EN
简 繁
    • Our Company
    • Culture & Values
    • Leadership
    • Global Locations
    • Corporate Compliance
    • Subsidiaries & Joint Ventures
    • Diversity & Inclusion
    • 20th Anniversary
    • Press Releases
    • Events
    • Tigermed Insights
    • Resource Library
    • Cloud Classroom
    • Sustainability & ESG Report
    • ESG Management
    • Corporate Responsibility
    • Preclinical
    • Early Phase
    • Phase II-III Clinical
    • Post-Marketing
    • Real World Study
    • Medicinal Chemistry
    • Compound Screening
    • DMPK
    • Safety & Toxicology
    • Bioanalytical
    • CMC
    • Medical Writing
    • Clinical Monitoring
    • Regulatory Affairs
    • Data Management and Statistical Analysis
    • Clinical Development Strategy
    • Decentralized Clinical Trials (DCTs)
    • Site Management (SMO)
    • Medical Device / IVD
    • Multi-region Clinical Trial (MRCT)
    • Vaccine Clinical Trial
    • Medical Imaging
    • Pharmacovigilance
    • Medical Translation
    • Quality Assurance
    • GMP Consulting
    • Central Laboratories
    • Functional Service Provider (FSP)
    • Participant Management
    • EDC System
    • Remote Follow-up Center
    • Cell and Gene Therapy
    • GLP-1 RA
    • Radiopharmaceutical
    • Infectious Diseases
    • Oncology
    • Hematology
    • Cardiovascular
    • Endocrinology
    • Rheumatology
    • Central Nervous System
    • Gastroenterology
    • Ophthalmology
  • Talent Development
  • Enjoy Your Life with Tigermed
  • Join Tigermed (China)
  • Join Tigermed (Global)
  • Corporate Governance
  • Financial Reports and Presentations
  • Announcements
  • Prospectus
  • Investor Contact
  • Business Enquiry / RFP
  • Client Service Center
  • Media & Investors Enquiry
  • Compliance Concern
Tigermed Logo - Contract Research Organization (CRO)
About Solutions Careers Investors Contact
简 繁

Investors

Announcements

  1. Home

  2. Investors

  3. Announcements

  • Mar 28, 2022

    PROPOSED ADOPTION OF 2022 SHARE APPRECIATION INCENTIVE SCHEME

    Read more

  • Mar 28, 2022

    PROPOSED ADOPTION OF 2022 SHARE APPRECIATION INCENTIVE SCHEME

    Read more

  • Mar 28, 2022

    PROPOSED ADOPTION OF THE A SHARE EMPLOYEE SHARE OWNERSHIP PLAN

    Read more

  • Mar 28, 2022

    PROPOSED ADOPTION OF THE A SHARE EMPLOYEE SHARE OWNERSHIP PLAN

    Read more

  • Mar 28, 2022

    FINAL DIVIDEND FOR THE YEAR ENDED DECEMBER 31, 2021

    Read more

  • Mar 28, 2022

    FINAL DIVIDEND FOR THE YEAR ENDED DECEMBER 31, 2021

    Read more

  • Mar 28, 2022

    ANNOUNCEMENT ON THE CHANGE IN USE OF PROCEEDS FROM H SHARES OFFERING

    Read more

  • Mar 28, 2022

    ANNOUNCEMENT ON THE CHANGE IN USE OF PROCEEDS FROM H SHARES OFFERING

    Read more

  • Mar 28, 2022

    (1) PROPOSED PARTIAL REPURCHASE AND CANCELLATION OF THE 2019 RESTRICTED A SHARES; (2) PROPOSED CHANGE OF THE REGISTERED CAPITAL OF THE COMPANY; AND (3) PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION

    Read more

  • Mar 28, 2022

    (1) PROPOSED PARTIAL REPURCHASE AND CANCELLATION OF THE 2019 RESTRICTED A SHARES; (2) PROPOSED CHANGE OF THE REGISTERED CAPITAL OF THE COMPANY; AND (3) PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION

    Read more

  • Mar 28, 2022

    ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2021

    Read more

  • Mar 28, 2022

    ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2021

    Read more

  • Mar 16, 2022

    DATE OF BOARD MEETING

    Read more

  • Mar 16, 2022

    DATE OF BOARD MEETING

    Read more

  • Mar 14, 2022

    ANNOUNCEMENT IN RELATION TO DEALINGS IN SECURITIES OF A DIRECTOR DURING THE BLACK-OUT PERIOD

    Read more

  • Mar 14, 2022

    ANNOUNCEMENT IN RELATION TO DEALINGS IN SECURITIES OF A DIRECTOR DURING THE BLACK-OUT PERIOD

    Read more

  • Mar 10, 2022

    ANNOUNCEMENT ON MAJOR OPERATING DATA FROM JANUARY TO FEBRUARY 2022

    Read more

  • Mar 10, 2022

    ANNOUNCEMENT ON MAJOR OPERATING DATA FROM JANUARY TO FEBRUARY 2022

    Read more

  • Mar 10, 2022

    PRELIMINARY RESULTS FOR THE YEAR OF 2021

    Read more

  • Mar 10, 2022

    PRELIMINARY RESULTS FOR THE YEAR OF 2021

    Read more

  • Mar 01, 2022

    Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2022

    Read more

  • Mar 01, 2022

    Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2022

    Read more

  • Feb 23, 2022

    Next Day Disclosure Return

    Read more

  • Feb 23, 2022

    Next Day Disclosure Return

    Read more

  • Feb 22, 2022

    Next Day Disclosure Return

    Read more

  • Feb 22, 2022

    Next Day Disclosure Return

    Read more

  • Feb 21, 2022

    Next Day Disclosure Return

    Read more

  • Feb 21, 2022

    Next Day Disclosure Return

    Read more

  • Feb 18, 2022

    Next Day Disclosure Return

    Read more

  • Feb 18, 2022

    Next Day Disclosure Return

    Read more



Previous Next
1 2 ... 16 17 18 19 20 21 22 ... 28 29


  • About Tigermed
  • Environment, ESG
  • Media and Resources
  • By Phase
  • Preclinical Development
  • Clinical Development
  • Integrated Capabilities
  • Therapeutic Expertise
  • Talent Development
  • Enjoy Your Life with Tigermed
  • Join Tigermed
  • Corporate Governance
  • Financial Reports and Presentations
  • Announcements
  • Prospectus
  • Investor Contact
  • Business Enquiry / RFP
  • Client Service Center
  • Media & Investors Enquiry
  • Compliance Concern

Footer

About

  • Our Company
  • Leadership
  • Global Locations
  • Press Releases
  • Events

Solutions

  • Preclinical
  • Early Phase
  • Phase II-III Clinical
  • Post-Marketing
  • Real World Study

Careers

  • Talent Development
  • Enjoy Your Life with Tigermed
  • Join Tigermed

Investors

  • Corporate Governance
  • Financial Reports and Presentations
  • Announcements
  • Prospectus
  • Investor Contact

Contact

  • Business Enquiry / RFP
  • Client Service Center
  • Media & Investors Enquiry
  • Compliance Concern

Global Headquarters

5F-6F, No. 508, Lujiatan Street, Puyan Street, Binjiang District,Hangzhou City,Zhejiang Province 310051

Tel: +86-571-28887227

Copyright © 2004- Tigermed All Rights Reserved. 浙ICP备11043991号-7

Cookies Privacy Policy Terms of Use
Cookies

The site uses cookies in order to collect data to provide general statistics to optimize site functionality and offer you a better experience. For more information, visit our Privacy Policy.

Contact us
Business Enquiry / RFP
Client Service Center
Media & Investors Enquiry
Compliance Concern